BioCina and NovaCina forge strategic alliance to offer biologics developers integrated drug substance and drug product solutions

BioCina Pty Ltd., a global end-to-end biologics Contract Development and Manufacturing Organisation (CDMO), and NovaCina Pty Ltd., a global fill-and-finish CDMO, announced a strategic partnership to provide integrated drug substance and drug product solutions for biologics developers.

Alzheimer’s Gets a New Definition

Alzheimer’s disease has a biologically based definition, according to criteria developed by an Alzheimer’s Association workgroup. The new criteria include biomarker classifications and a revised

Read More »